Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$657K Sell
25,496
-10,933
-30% -$331K 0.03% 371
2026
Q1
$1.04M Buy
+36,429
New +$927K 0.06% 337
2024
Q4
Sell
-58,662
Closed -$2.01M 834
2024
Q3
$2.01M Sell
58,662
-27,741
-32% -$1.02M 0.18% 208
2024
Q2
$3.35M Buy
86,403
+54,690
+172% +$1.96M 0.32% 90
2024
Q1
$1.11M Buy
+31,713
New +$1.08M 0.1% 313
2023
Q4
Sell
-46,881
Closed -$1.27M 672
2023
Q3
$1.27M Sell
46,881
-13,055
-22% -$331K 0.16% 214
2023
Q2
$1.44M Buy
59,936
+17,053
+40% +$475K 0.2% 180
2023
Q1
$1.32M Buy
42,883
+11,547
+37% +$351K 0.18% 205
2022
Q4
$895K Sell
31,336
-23,048
-42% -$621K 0.14% 254
2022
Q3
$1.11M Buy
54,384
+781
+1% +$14K 0.17% 192
2022
Q2
$726K Buy
+53,603
New +$629K 0.06% 497

Other funds holding TRMD

PDT Partners's TRMD Position: Q2 2026 in Review

PDT Partners reduced its TORM (TRMD) stake by 30% in Q2 2026, selling an estimated $331K and leaving 25,496 shares worth $657K. The position accounts for 0.03% of the portfolio, ranked #371.

PDT Partners first reported a position in TRMD in Q2 2022 and has held it in 11 quarters since. The position peaked at $3.35M in Q2 2024. 151 funds tracked by Wall St. Rank hold TRMD as of Q2 2026.

  • PDT Partners held 25,496 shares of TORM worth $657K as of Q2 2026.
  • PDT Partners sold 10,933 TORM shares in Q2 2026, an estimated $331K.
  • TORM made up 0.03% of PDT Partners's portfolio in Q2 2026, its #371 holding.
  • PDT Partners first reported a position in TORM in Q2 2022 and has held it in 11 quarters since.
  • PDT Partners's TORM position peaked at $3.35M in Q2 2024.
  • 151 funds tracked by Wall St. Rank held TORM as of Q2 2026.

Based on PDT Partners's 13F filing for Q2 2026, filed 14 Aug 2026.